BioSpace News Archive

BriaCell is pleased to announce the presentation of results from clinical studies with its lead product candidate, Bria-IMT™, summarized in a poster session held January 25-27 during the 2021 Keystone Symposium, “Emerging Cell Therapies: Realizing the Vision of NextGen Cell Therapeutics,” a virtual scientific conference.

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that three abstracts from multiple clinical studies will be featured at the International Association for the Study of Lung Cancer (IASLC)

Eloxx Pharmaceuticals announced a Publication titled: “ A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX-02 in Healthy Subjects”

Surgical suture is a medical device used to close a wound after surgery or injury. There are chances of infection at the wound site after the application of suture.

The global circulating tumor cell testing market is projected to show upward revenues curve during the forecast period of 2020 to 2030.

Speculum is a device that is used by the physician to view inside any hollow part of the body to diagnose or treat disease. It is made up of stainless steel, plastic, and metal.

Dante Labs has already analysed two million and a half COVID-19 RT-PCR tests and sequenced more than 30,000 human whole genomes thanks to its Immensa™ Genome Platform

Microcaps AG, a developer of formulation, processes and equipment to generate precision microcapsules, announced that it has closed a CHF 5 million seed financing round co-led by Helvetica Capital and Zürcher Kantonalbank.

Photocure ASA : The Bladder Cancer Company focused on delivering transformative solutions to improve the lives of bladder cancer patients, announces that it has entered into a partnership agreement with Asieris MediTech Co., Ltd., a division of Jiangsu Yahong Meditech Co., Ltd., whereby Asieris has obtained exclusive rights to register and commercialize Hexvix® in Mainland China and Taiwan.

Asieris Pharmaceuticals announced that the company has entered into a license agreement with Photocure ASA to exclusively register and commercialize Hexvix® in Mainland China and Taiwan.